does semaglutide affect your heart in Cardiometabolic Diseases: SELECTing the Target Population Wegovy® for Cardiovascular Risk |

Participants were randomly assigned to receive either a once-weekly subcutaneous semaglutide or a placebo for 68 weeks in combination with lifestyle intervention

Key Takeaways Semaglutide capitalizes on its unique formulation, mimicking the naturally occurring GLP-1 hormone, to deliver benefits and improve blood sugar levels and weight management

First, gastric emptying slows dramatically

This, coupled with the dramatic weight-loss successes that are visibly noticeable in formerly overweight celebrities, makes semaglutides, Ozempic, Wegovy, and GLP-1 injections a VERY hot topic

Your eligibility to take the medication for weight loss will also be assessed